Health and Beauty CytoDyn Inc.’s Vyrologix™ (leronlimab-Vyrologix) shows impressive results in critically ill COVID-19 patientsBy Lion's DenJanuary 28, 2021 CytoDyn Inc., a late-stage biotechnology company developing CCR5inhibitingdrug leronlimab-Vyrologix, showed impressive results in improving the immune function of critically ill…
